On May 25, 2021 Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, reported that the company will participate in the 2021 Jefferies Healthcare Conference being held virtually from June 1-4, 2021 (Press release, Sierra Oncology, MAY 25, 2021, View Source [SID1234580558]). Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra will present an overview of the company on Thursday, June 3 from 1:30 – 1:55 pm ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast at the time noted above, and a replay will be made available following the presentation, on the Investors section of Sierra’s corporate website in the Events & Webcast tab.